Pharmacodynamic effects of seliciclib (r-roscovitine, cyc202) in patients with undifferentiated nasopharyngeal cancer (NPC) using a window trial design

Autoria(s): Hsieh, W.S.; Peh, B.K.; Loh, T.; Chiao, J.H.; Soo, R.; Green, S.R.; Lai, Y.F.; Salto-Tellez, Manuel; Soong, R.; Goh, B.C.
Data(s)

2006
Identificador

http://pure.qub.ac.uk/portal/en/publications/pharmacodynamic-effects-of-seliciclib-rroscovitine-cyc202-in-patients-with-undifferentiated-nasopharyngeal-cancer-npc-using-a-window-trial-design(342aa022-ebdf-4ba9-b6af-f852034dea7b).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Hsieh , W S , Peh , B K , Loh , T , Chiao , J H , Soo , R , Green , S R , Lai , Y F , Salto-Tellez , M , Soong , R & Goh , B C 2006 , ' Pharmacodynamic effects of seliciclib (r-roscovitine, cyc202) in patients with undifferentiated nasopharyngeal cancer (NPC) using a window trial design ' EJC SUPPLEMENTS , vol 4 , pp. 88-88 .
Tipo

article
Acesso ao item digital